The U.S. Food and Drug Administration’s approval of a drug used in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer marks the end of numerous failed attempts to improve survival for those with the deadly disease.
A new study conducted at cancer centers around the country, including at Georgetown Lombardi Comprehensive Cancer Center, supports the routine use of a radiation treatment for prostate cancer that delivers a high dose of therapy in a very short time frame.
Former second lady of the United States Jill Biden joined supporters, survivors, politicos and friends for the annual NewsBash event, which helps raise awareness for breast cancer and this year raised funds for Georgetown's Capital Breast Care Center.
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
To launch the start of training season for their Second Annual Walk, the Walking Warriors Battling Breast Cancer held a grand start party attended by dozens of breast cancer survivors and their friends and family.
The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center, a mother of two and grandmother of four, is now in “complete remission” after a lengthy battle with stage-three non-Hodgkin lymphoma.
The Movement for Multiple Sclerosis (MS) Program, first piloted by Georgetown University Medical Center and MedStar Georgetown University Hospital in November 2017, offers an innovative music and movement based course for patients with multiple sclerosis.